RIFATER

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 7 USDMF, 5 CEP/COS, 1 JDMF, 2 EU WC, 8 NDC API, 5 Listed Suppliers

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

FINISHED DOSAGE FORMULATIONS

199 FDF Dossiers, 61 FDA Orange Book, 56 Europe, 3 Canada, 1 Australia, 61 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 12 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 4 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 4 Actylis, 2 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 7 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 14 Kerry, 4 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 6 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 30 Direct Compression, 28 Granulation, 28 Thickeners and Stabilizers, 25 Disintegrants & Superdisintegrants, 24 Lubricants & Glidants, 16 Co-Processed Excipients, 16 Film Formers & Plasticizers, 15 Coating Systems & Additives, 14 Parenteral, 14 Taste Masking, 14 Solubilizers, 9 Controlled & Modified Release, 9 Chewable & Orodispersible Aids, 8 Empty Capsules, 8 Topical, 7 Emulsifying Agents, 4 API Stability Enhancers, 4 Rheology Modifiers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 14 Regulatory FDF Prices

MARKET PLACE

14 APIs, 6 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 3 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

Xls

Filters

RIFATER

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for RIFATER? Find Coloring Agents used in RIFATER to address drug delivery challenges on PharmaCompass.

RIFATER

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

7 USDMF

5 CEP/COS

1 JDMF

2 EU WC

8 NDC API

5 Listed Suppliers

DEVELOPMENTS

10 Drugs in Development

FINISHED DOSAGE FORMULATIONS

199 FDF Dossiers

61 FDA Orange Book

56 Europe

3 Canada

1 Australia

61 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

12 SPI Pharma

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

4 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

4 Actylis

2 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

17 BASF

1 CD Formulation

7 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

14 Kerry

4 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

18 Microlex e.U

2 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

3 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qualicaps

27 Roquette

2 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

5 Silverline Chemicals

1 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

6 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders

30 Direct Compression

28 Granulation

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons